SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001564590-20-042648
Filing Date
2020-09-04
Accepted
2020-09-04 16:01:18
Documents
9

Document Format Files

Seq Description Document Type Size
1 S-3 arav-s3.htm S-3 676748
2 EX-1.1 arav-ex11_198.htm EX-1.1 327678
3 EX-4.3 arav-ex43_6.htm EX-4.3 411922
4 EX-5.1 arav-ex51_7.htm EX-5.1 41162
5 EX-23.1 arav-ex231_8.htm EX-23.1 3204
6 GRAPHIC gfubphbwcsgd000001.jpg GRAPHIC 4772
7 GRAPHIC gfubphbwcsgd000003.jpg GRAPHIC 4795
8 GRAPHIC g20sqyk3ad01000001.jpg GRAPHIC 4218
9 GRAPHIC gfubphbwcsgd000002.jpg GRAPHIC 4791
  Complete submission text file 0001564590-20-042648.txt   1487992
Mailing Address RIVER OAKS TOWER 3730 KIRBY DRIVE, SUITE 1200 HOUSTON TX 77098
Business Address RIVER OAKS TOWER 3730 KIRBY DRIVE, SUITE 1200 HOUSTON TX 77098 936-355-1910
Aravive, Inc. (Filer) CIK: 0001513818 (see all company filings)

IRS No.: 264106690 | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-248612 | Film No.: 201161899
SIC: 2834 Pharmaceutical Preparations